Canadian COVID-19 vaccine that can be inhaled to enter Phase 2 human trials
New Canadian COVID-19 vaccine that can be inhaled to enter Phase 2 human trials. The vaccine is being developed at McMaster University in Hamilton, Ontario. In a news release, Dr ...
